Puma Biotech (PBYI) Tops Q3 EPS by 5c

Puma Biotech (NASDAQ: PBYI) reported Q3 EPS of $0.21, $0.05 better than the analyst estimate of $0.16. Revenue for the quarter came in at $54.5 million versus the consensus estimate of $57.5 million.

For earnings history and earnings-related data on Puma Biotech (PBYI) click here.

You May Also Be Interested In

• Hurco (HURC) Reports Q2 Loss of $0.37
• U.S. economy adds 172,000 jobs in May, topping expectations
• Intuitive Machines (LUNR) call put ratio 1.9 calls to 1 put as share price down 9%